PRMT5 Inhibition Modulates E2F1 Methylation and Gene-Regulatory Networks Leading to Therapeutic Efficacy in JAK2V617F-Mutant MPN.

Cancer Discovery
Friederike PastoreRoss L Levine

Abstract

We investigated the role of PRMT5 in myeloproliferative neoplasm (MPN) pathogenesis and aimed to elucidate key PRMT5 targets contributing to MPN maintenance. PRMT5 is overexpressed in primary MPN cells, and PRMT5 inhibition potently reduced MPN cell proliferation ex vivo. PRMT5 inhibition was efficacious at reversing elevated hematocrit, leukocytosis, and splenomegaly in a model of JAK2V617F+ polycythemia vera and leukocyte and platelet counts, hepatosplenomegaly, and fibrosis in the MPLW515L model of myelofibrosis. Dual targeting of JAK and PRMT5 was superior to JAK or PRMT5 inhibitor monotherapy, further decreasing elevated counts and extramedullary hematopoiesis in vivo. PRMT5 inhibition reduced expression of E2F targets and altered the methylation status of E2F1 leading to attenuated DNA damage repair, cell-cycle arrest, and increased apoptosis. Our data link PRMT5 to E2F1 regulatory function and MPN cell survival and provide a strong mechanistic rationale for clinical trials of PRMT5 inhibitors in MPN. SIGNIFICANCE: Expression of PRMT5 and E2F targets is increased in JAK2V617F+ MPN. Pharmacologic inhibition of PRMT5 alters the methylation status of E2F1 and shows efficacy in JAK2V617F/MPLW515L MPN models and primary sample...Continue Reading

References

Sep 15, 2004·Trends in Biochemical Sciences·Adrian P BrackenKristian Helin
Mar 23, 2005·Lancet·E Joanna BaxterUNKNOWN Cancer Genome Project
Apr 29, 2005·The New England Journal of Medicine·Robert KralovicsRadek C Skoda
Jan 20, 2009·Molecular Cell·Mark T Bedford, Steven G Clarke
Apr 25, 2009·British Journal of Haematology·Véronique Gelsi-BoyerDaniel Birnbaum
May 29, 2009·The New England Journal of Medicine·François DelhommeauOlivier A Bernard
Jul 6, 2010·Nature Genetics·Thomas ErnstNicholas C P Cross
Feb 9, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ayalew TefferiAnimesh Pardanani
Oct 7, 2011·Trends in Biochemical Sciences·Vrajesh KarkhanisSaïd Sif
Jan 11, 2012·The Journal of Experimental Medicine·Kai B KaufmannHeike L Pahl
Feb 14, 2012·The EMBO Journal·Er-Chieh ChoNicholas B La Thangue
Mar 2, 2012·The New England Journal of Medicine·Claire HarrisonGiovanni Barosi
Mar 2, 2012·The New England Journal of Medicine·Srdan VerstovsekHagop M Kantarjian
Dec 14, 2012·Nature Reviews. Cancer·Yanzhong Yang, Mark T Bedford
Feb 19, 2013·Cytokine & Growth Factor Reviews·Hans C Hasselbalch
May 21, 2013·DNA Repair·Yannick Auclair, Stéphane Richard
Mar 4, 2014·Biochimica Et Biophysica Acta·Sitaram Gayatri, Mark T Bedford
Feb 11, 2015·Cellular and Molecular Life Sciences : CMLS·Nicole StopaDavid Shechter
Aug 11, 2015·The Journal of Clinical Investigation·Fan LiuStephen D Nimer
Mar 31, 2016·Experimental Hematology·Sarah M GreenblattStephen D Nimer
Jan 7, 2017·Molecular Cell·Roméo S Blanc, Stéphane Richard
Feb 6, 2017·Blood·Adam J Mead, Ann Mullally
May 28, 2017·The Journal of Experimental Medicine·Eunsun KimPatrick Viatour
Oct 1, 2017·Journal of Hematology & Oncology·Srdan VerstovsekVikas Gupta
Dec 9, 2017·Blood Cancer Journal·Roberta ZiniUNKNOWN AGIMM (AIRC Gruppo Italiano Malattie Mieloproliferative) investigators
Jul 24, 2018·ACS Medicinal Chemistry Letters·Zahid Q BondayRobert M Campbell
Mar 25, 2019·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Wendi XiaoYucheng Zhong
Oct 16, 2019·Nature Structural & Molecular Biology·Aliaksandra RadzisheuskayaKristian Helin

❮ Previous
Next ❯

Citations

Dec 18, 2020·Frontiers in Immunology·Vasundhara SharmaGary W Reuther
Mar 2, 2021·Hematology/oncology Clinics of North America·Jakub Szybinski, Sara C Meyer
Mar 2, 2021·Hematology/oncology Clinics of North America·Andrew DunbarRoss Levine
May 31, 2021·Current Opinion in Pharmacology·Ernesto GuccioneSlim Mzoughi
Jul 17, 2021·Current Opinion in Hematology·Daniel SascaMichael W M Kühn
Aug 27, 2021·Blood·Hsuan-Ting Huang, Maria E Figueroa
Sep 18, 2021·Cell Death & Disease·Tian XiaPeipei Xu
Nov 16, 2021·Leukemia & Lymphoma·Prithviraj Bose, Ruben A Mesa

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis